Vergent Bioscience is a clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by significantly improving the visibility of tumors. Vergent’s lead compound, VGT-309, is a tumor-targeted fluorescent imaging agent intentionally designed to enable surgeons to see previously undetected or difficult-to-find tumors during surgery in real-time, ensuring all tumor tissue is removed. We are first evaluating VGT-309 in lung cancer, with the potential to expand its application to a wide range of solid tumors. Our approach directly addresses the clinical need and market opportunity for advanced visualization in open, laparoscopic, and robotic-assisted surgical procedures.
| Website | https://www.vergentbio.com/ |
| Employees | 6 (0 on RocketReach) |
| Founded | 2016 |
| Address | 5810 West 78th Street Suite 222, Minneapolis, Minnesota 55439, US |
| Industry | Biotechnology |
| Keywords | Minimally Invasive Surgery, Medical Devices, Robotic Surgery, Surgical Imaging, Surgical Technology, Oncology, Medical Imaging, Biotechnology, Clinical Trials, Cancer Treatment, Healthcare Technology, Surgical Tools, Clinical Stage, Drug Delivery, Therapeutic Agents, Bioscience, Innovative Therapies, Precision Medicine, Pharmaceutical |
| Competitors | GE HealthCare, Roche, Thermo Fisher Scientific, Agilent Technologies, MilliporeSigma, PerkinElmer, Inc., Bio-Techne, Promega Corporation, Millennium Health, Santa Cruz Biotechnology (SCBT) +39 more (view full list) |
Looking for a particular Vergent Bioscience employee's phone or email?
Vergent Bioscience Questions
Vergent Bioscience is based in Minneapolis, Minnesota.
Related Companies
